{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:42:19Z","timestamp":1793947339777,"version":"4.8.0"},"reference-count":46,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,3,15]],"date-time":"2009-03-15T00:00:00Z","timestamp":1237075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Pathology Medicine"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Prediction of progression from pre\u2010malignant oral mucosal lesions to malignancy, or recurrence of an existing oral squamous cell carcinoma (OSCC), is an important clinical problem in oral medicine.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> This study presents a follow\u2010up of a study published in 2002. Samples from 54 patients with OSCC, 45 with oral lichen planus (OLP) and 45 with hyperkeratosis (clinically leukoplakia), diagnosed between 1987 and 1996, were analysed for TP53 protein expression and <jats:italic>TP53<\/jats:italic> mutation. Follow\u2010up was 11\u201317\u2003years for OSCC (mean 13.3), 12\u201322\u2003years for OLP (mean 15.9) and 12\u201317\u2003years for hyperkeratosis (mean 14.5).<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Of the 54 OSCC patients, 28 experienced recurrent disease, 21 died of OSCC, 22 died of other causes. Of the 14 OSCC patients with mutated <jats:italic>TP53<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2003=\u200311), the cancer recurred in eight (57%) and in 20\/39 (51%) without mutation. Expression of TP53 protein was significantly associated with reduced overall survival. Among OLP patients, nine were <jats:italic>TP53\u2010<\/jats:italic>mutated out of 31 tested. One <jats:italic>TP53\u2010<\/jats:italic>mutated OLP patient developed OSCC in a different site. Of the hyperkeratosis patients, three were mutated of 22 tested. One hyperkeratosis patient (non\u2010mutated) developed OSCC in the same site.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold>  <jats:italic>TP53<\/jats:italic> mutations can exist in benign oral mucosal lesions for many years without progression to malignancy. No association was found between TP53 protein expression or <jats:italic>TP53<\/jats:italic> mutation and recurrence of OSCC or disease\u2010related survival. Overall survival was reduced in patients with positive TP53 protein expression.<\/jats:p>","DOI":"10.1111\/j.1600-0714.2009.00766.x","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T11:03:35Z","timestamp":1247223815000},"page":"565-571","source":"Crossref","is-referenced-by-count":33,"title":["Role of TP53 in the progression of pre\u2010malignant and malignant oral mucosal lesions. A follow\u2010up study of 144 patients"],"prefix":"10.1111","volume":"38","author":[{"given":"H. M.","family":"\u00d6gmundsd\u00f3ttir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. P.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"key":"e_1_2_6_3_2","unstructured":"Icelandic Cancer Registry.http:\/\/www.krabbameinsskra.is\/(last accessed on July 2008)."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2007.00579.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1549"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.02.009"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1078-0432.1160.11.3","article-title":"Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma","volume":"11","author":"Yu Z","year":"2005","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/154405910308201115"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20858"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2005.07.023"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00474.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2004.08.013"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2004.12.008"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0572"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2007.00584.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00491.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(03)00305-6"},{"key":"e_1_2_6_18_2","first-page":"1860","article-title":"Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma","volume":"7","author":"Partridge M","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_19_2","first-page":"3893","article-title":"A case\u2010control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization","volume":"60","author":"Partridge M","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-6-62"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(02)00163-X"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2007.06.013"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.21235.x"},{"key":"e_1_2_6_24_2","first-page":"1217","article-title":"High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non\u2010invasive lesions","volume":"10","author":"Ahomadegbe JC","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_6_25_2","first-page":"279","article-title":"P53 genotyping \u2010 an effective concept for molecular testing of head and neck cancer?","volume":"4","author":"Dahse R","year":"1999","journal-title":"Int J Mol Med"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.159"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(02)00064-7"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(01)00301-2"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240560404"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00018.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1998.tb01940.x"},{"key":"e_1_2_6_32_2","first-page":"1702","article-title":"Predicting cancer development in oral leukoplakia: ten years of translational research","volume":"6","author":"Lee JJ","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2004.03.011"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<345::AID-IJC2>3.0.CO;2-N"},{"key":"e_1_2_6_35_2","first-page":"161","author":"Soames JV","year":"1998","journal-title":"Oral pathol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.2.98"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1998.tb01963.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-008-9022-3"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073770"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2007.00517.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2006.01349.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2007.06.006"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210302"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1294"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690290"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0186"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00096.x"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2009.00766.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0714.2009.00766.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:52:41Z","timestamp":1697071961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2009.00766.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1600-0714.2009.00766.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2009.00766.x","archive":["Portico"],"relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"value":"0904-2512","type":"print"},{"value":"1600-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}